rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-7-8
|
pubmed:abstractText |
Aprotinin was used frequently in children undergoing congenital heart operations with the aim of reducing bleeding, until it was taken off the market after adult studies reported increased renal failure and death. We evaluated the safety of aprotinin in a large multicenter cohort of children undergoing congenital heart operations.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1552-6259
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14-21
|
pubmed:dateRevised |
2011-4-1
|
pubmed:meshHeading |
pubmed-meshheading:20609740-Aprotinin,
pubmed-meshheading:20609740-Cardiac Surgical Procedures,
pubmed-meshheading:20609740-Child, Preschool,
pubmed-meshheading:20609740-Cohort Studies,
pubmed-meshheading:20609740-Databases, Factual,
pubmed-meshheading:20609740-Female,
pubmed-meshheading:20609740-Heart Defects, Congenital,
pubmed-meshheading:20609740-Hemostatics,
pubmed-meshheading:20609740-Hospital Mortality,
pubmed-meshheading:20609740-Humans,
pubmed-meshheading:20609740-Infant,
pubmed-meshheading:20609740-Male,
pubmed-meshheading:20609740-Renal Insufficiency,
pubmed-meshheading:20609740-Retrospective Studies
|
pubmed:year |
2010
|
pubmed:articleTitle |
Safety of aprotinin in congenital heart operations: results from a large multicenter database.
|
pubmed:affiliation |
Division of Pediatric Cardiology, Duke University Medical Center, Durham, North Carolina 27715, USA. sara.pasquali@duke.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|